Reshape Lifesciences Inc
(RSLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Operating Expenses | 16,177 | 24,212 | 36,270 | 28,026 | 18,122 |
| Operating Income | -16,177 | -24,212 | -36,270 | -28,026 | -18,122 |
| Interest Expense | 1,258 | 4,104 | 2,684 | 1,649 | 710 |
| Other Income | 88 | -3,613 | 1,080 | 1,100 | 1,141 |
| Pre-tax Income | -17,347 | -31,929 | -37,874 | -28,575 | -17,691 |
| Net Income Continuous | -17,347 | -31,929 | -37,874 | -28,575 | -17,691 |
| Net Income | $-17,347 | $-31,929 | $-37,874 | $-28,575 | $-17,691 |
| EPS Basic Total Ops | -2.06 | -6.42 | -13.50 | -11.69 | -34.19 |
| EPS Basic Continuous Ops | -2.06 | -6.42 | -13.50 | -11.69 | -34.19 |
| EPS Diluted Total Ops | -2.06 | -6.42 | -13.50 | -11.69 | -34.19 |
| EPS Diluted Continuous Ops | -2.06 | -6.42 | -13.50 | -11.69 | -34.19 |
| EBITDA(a) | $-15,414 | $-22,296 | $-35,107 | $-27,034 | $-18,026 |